328 related articles for article (PubMed ID: 25637276)
1. Synthesis and pharmacological evaluation of ¹¹C-labeled piperazine derivative as a PET probe for sigma-2 receptor imaging.
Selivanova SV; Toscano A; Abate C; Berardi F; Müller A; Krämer SD; Schibli R; Ametamey SM
Nucl Med Biol; 2015 Apr; 42(4):399-405. PubMed ID: 25637276
[TBL] [Abstract][Full Text] [Related]
2. Analogues of σ receptor ligand 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with added polar functionality and reduced lipophilicity for potential use as positron emission tomography radiotracers.
Abate C; Niso M; Lacivita E; Mosier PD; Toscano A; Perrone R
J Med Chem; 2011 Feb; 54(4):1022-32. PubMed ID: 21229979
[TBL] [Abstract][Full Text] [Related]
3. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
Arponen E; Helin S; Marjamäki P; Grönroos T; Holm P; Löyttyniemi E; Någren K; Scheinin M; Haaparanta-Solin M; Sallinen J; Solin O
J Nucl Med; 2014 Jul; 55(7):1171-7. PubMed ID: 24799619
[TBL] [Abstract][Full Text] [Related]
4. Design and Investigation of a [
Yang D; Comeau A; Bowen WD; Mach RH; Ross BD; Hong H; Van Dort ME
Mol Pharm; 2017 Mar; 14(3):770-780. PubMed ID: 28135101
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vivo evaluation of [18F]N-(2-benzofuranylmethyl)-N'-[4-(2-fluoroethoxy)benzyl]piperazine, a novel σ1 receptor PET imaging agent.
Moussa IA; Banister SD; Giboureau N; Meikle SR; Kassiou M
Bioorg Med Chem Lett; 2011 Nov; 21(22):6820-3. PubMed ID: 21962578
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and in vivo evaluation of a new PET radioligand for studying sigma-2 receptors.
Kassiou M; Dannals RF; Liu X; Wong DF; Ravert HT; Scheffel UA
Bioorg Med Chem; 2005 Jun; 13(11):3623-6. PubMed ID: 15862990
[TBL] [Abstract][Full Text] [Related]
7. Development of 3,4-dihydroisoquinolin-1(2H)-one derivatives for the Positron Emission Tomography (PET) imaging of σ₂ receptors.
Abate C; Selivanova SV; Müller A; Krämer SD; Schibli R; Marottoli R; Perrone R; Berardi F; Niso M; Ametamey SM
Eur J Med Chem; 2013 Nov; 69():920-30. PubMed ID: 24161678
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vivo evaluation of [11C]SA6298 as a PET sigma1 receptor ligand.
Kawamura K; Ishiwata K; Tajima H; Ishii S; Shimada Y; Matsuno K; Homma Y; Senda M
Nucl Med Biol; 1999 Nov; 26(8):915-22. PubMed ID: 10708305
[TBL] [Abstract][Full Text] [Related]
9. Preclinical Evaluation of Benzazepine-Based PET Radioligands (
Haider A; Herde AM; Krämer SD; Varisco J; Keller C; Frauenknecht K; Auberson YP; Temme L; Robaa D; Sippl W; Schibli R; Wünsch B; Mu L; Ametamey SM
J Nucl Med; 2019 Aug; 60(8):1167-1173. PubMed ID: 30683765
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of [18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor.
Elsinga PH; Kawamura K; Kobayashi T; Tsukada H; Senda M; Vaalburg W; Ishiwata K
Synapse; 2002 Mar; 43(4):259-67. PubMed ID: 11835521
[TBL] [Abstract][Full Text] [Related]
11. Exploring the importance of piperazine N-atoms for sigma(2) receptor affinity and activity in a series of analogs of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28).
Berardi F; Abate C; Ferorelli S; Uricchio V; Colabufo NA; Niso M; Perrone R
J Med Chem; 2009 Dec; 52(23):7817-28. PubMed ID: 19842660
[TBL] [Abstract][Full Text] [Related]
12. Novel derivatives of 1-cyclohexyl-4-[3-(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)propyl]piperazine (PB28) with improved fluorescent and σ receptors binding properties.
Abate C; Niso M; Marottoli R; Riganti C; Ghigo D; Ferorelli S; Ossato G; Perrone R; Lacivita E; Lamb DC; Berardi F
J Med Chem; 2014 Apr; 57(8):3314-23. PubMed ID: 24697311
[TBL] [Abstract][Full Text] [Related]
13. Arylamides hybrids of two high-affinity σ2 receptor ligands as tools for the development of PET radiotracers.
Abate C; Ferorelli S; Contino M; Marottoli R; Colabufo NA; Perrone R; Berardi F
Eur J Med Chem; 2011 Sep; 46(9):4733-41. PubMed ID: 21684636
[TBL] [Abstract][Full Text] [Related]
14.
Ye J; Wang L; Deuther-Conrad W; Chen Y; Zhang X; Zhang J; Huang Y; Brust P; Jia H
J Labelled Comp Radiopharm; 2019 Jun; 62(8):425-437. PubMed ID: 30991462
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of ¹⁸F labeled fluoro-oligo-ethoxylated 4-benzylpiperazine derivatives for sigma-1 receptor imaging.
Wang X; Li Y; Deuther-Conrad W; Xie F; Chen X; Cui MC; Zhang XJ; Zhang JM; Steinbach J; Brust P; Liu BL; Jia HM
Bioorg Med Chem; 2013 Jan; 21(1):215-22. PubMed ID: 23199475
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of fluorine-18-labeled SA4503 as a selective sigma1 receptor ligand for positron emission tomography.
Kawamura K; Tsukada H; Shiba K; Tsuji C; Harada N; Kimura Y; Ishiwata K
Nucl Med Biol; 2007 Jul; 34(5):571-7. PubMed ID: 17591557
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel 4-benzylpiperazine ligands for sigma-1 receptor imaging.
Li ZJ; Ren HY; Cui MC; Deuther-Conrad W; Tang RK; Steinbach J; Brust P; Liu BL; Jia HM
Bioorg Med Chem; 2011 May; 19(9):2911-7. PubMed ID: 21481592
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of spirocyclic 3-(3-fluoropropyl)-2-benzofurans as sigma1 receptor ligands for neuroimaging with positron emission tomography.
Maestrup EG; Fischer S; Wiese C; Schepmann D; Hiller A; Deuther-Conrad W; Steinbach J; Wünsch B; Brust P
J Med Chem; 2009 Oct; 52(19):6062-72. PubMed ID: 19791807
[TBL] [Abstract][Full Text] [Related]
19. Small-animal PET with a σ-ligand, 11C-SA4503, detects spontaneous pituitary tumors in aged rats.
Ramakrishnan NK; Rybczynska AA; Visser AK; Marosi K; Nyakas CJ; Kwizera C; Sijbesma JW; Elsinga PH; Ishiwata K; Pruim J; Dierckx RA; van Waarde A
J Nucl Med; 2013 Aug; 54(8):1377-83. PubMed ID: 23785170
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and radiopharmacological evaluation of a high-affinity and metabolically stabilized 18F-labeled bombesin analogue for molecular imaging of gastrin-releasing peptide receptor-expressing prostate cancer.
Richter S; Wuest M; Krieger SS; Rogers BE; Friebe M; Bergmann R; Wuest F
Nucl Med Biol; 2013 Nov; 40(8):1025-34. PubMed ID: 23969085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
